Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cognis Licenses Weight Management and Heart Health Ingredients - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Cognis Licenses Weight Management and Heart Health Ingredients

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Through an ongoing collaboration, Cognis, Dusseldorf, Germany, has licensed two additional product candidates from InterMed Discovery (IMD), Dortmund, Germany. One functional ingredient shows promise in the area of weight management and the other has potential heart health benefits. Cognis has now licensed two active ingredients supporting weight management from IMD; both have exhibited positive results in vitro and in vivo. Extract development has been finalized and subsequent safety studies are underway. The heart health product candidate has shown interesting efficacy results in vitro and Cognis plans to carry out preclinical studies later this year.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters